FDA Clears New Blood Test that Could Speed Alzheimer’s Diagnosis and Treatment

Health & LifestyleNews
143

Listen to article (english)

Translate to Spanish or other 102 languages!

With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes
With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes

Mega Doctor News

- Advertisement -

By George Washington University

Newswise – With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed.

This week, the FDA cleared Roche’s Elecsys pTau181 test — only the second blood-based biomarker test approved this year for Alzheimer’s disease. The test, developed with Eli Lilly, gives primary care physicians a faster way to help rule out Alzheimer’s in patients showing signs of cognitive decline, potentially reducing reliance on costly PET scans and getting patients to answers — and treatment — sooner.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
HHSC Encourages Preventive Care During Breast Cancer Awareness Month
Next article
STHS Children’s Partners with Spirit Halloween for Pre-Halloween Party for Patients

More Articles

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

STHS Clinics Surgeon Dr. Miguel Rodriguez Earns Prestigious National Recognition

Miguel Rodriguez, DO, FACS, a general, robotic and bariatric surgeon with STHS Clinics, has been inducted as a Fellow of the American College of Surgeons (ACS), earning the prestigious FACS designation.

AACT Now Launches Rally the Vote Across Rio Grande Valley

The Advocacy Alliance Center of Texas, or AACT Now, launched its Rally the Vote initiative Thursday, bringing together community organizations and regional leaders to expand access to nonpartisan voter information across the Rio Grande Valley.

Healthcare Alliance Recognizes Texas Oncology Investment in Valley Cancer Care

Maritza Gonzalez, founder and director of the Texas Healthcare Alliance Chamber of Commerce, recognized Texas Oncology’s continued investment in Rio Grande Valley cancer care during the Sept. 29 grand opening of the Texas Oncology McAllen West clinic.
- Advertisement -